StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Antidilutive Securities Excluded from Diluted EPS by Year

Antidilutive Securities Excluded from Diluted EPS: ESPP Shares (thousand shares)

Natera Antidilutive Securities Excluded from Diluted EPS: 34.00 k_shares in FY2025, down 15.0% from a year earlier.

Latest, FY2025
34.00
Period ended Dec 31, 2025
Change on a year earlier
-15.0%
40.00 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Reported in Form 10-K/10-Q Note — Net Loss Per Share (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAntidilutive Securities Excluded from Diluted EPS: ESPP Shares (thousand shares)Year on yearSource
FY2025Dec 31, 202534.00-15.0%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 202440.00-54.5%Form 10-K (2026-02-27) ↗
FY2023Dec 31, 202388.00-2.2%Form 10-K (2026-02-27) ↗
FY2022Dec 31, 202290.00+172.7%Form 10-K (2025-02-28) ↗
FY2021Dec 31, 202133.00-10.8%Form 10-K (2024-02-29) ↗
FY2020Dec 31, 202037.00+15.6%Form 10-K (2023-03-01) ↗
FY2019Dec 31, 201932.00-23.8%Form 10-K (2022-02-25) ↗
FY2018Dec 31, 201842.00–Form 10-K (2021-02-26) ↗
FY2017Dec 31, 20170.00–Form 10-K (2020-03-02) ↗
FY2016Dec 31, 20160.00–Form 10-K (2019-03-15) ↗

Cite this data

StockData. (2026). Natera Antidilutive Securities Excluded from Diluted EPS, annual FY2016–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/antidilutive-espp-shares

See every metric in the Natera KPI table. Data updated Nov 2, 2026.